"Immunoglobulin Idiotypes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains.
Descriptor ID |
D007130
|
MeSH Number(s) |
D12.644.541.500.745 D12.776.124.486.485.680.745 D12.776.124.790.651.680.745 D12.776.377.715.548.680.745 D23.050.550.750 G02.111.570.060.425.580 G12.500.450
|
Concept/Terms |
Immunoglobulin Idiotypes- Immunoglobulin Idiotypes
- Idiotype, Immunoglobulin
- Immunoglobulin Idiotype
- Idiotypes, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin Idiotypes".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin Idiotypes".
This graph shows the total number of publications written about "Immunoglobulin Idiotypes" by people in this website by year, and whether "Immunoglobulin Idiotypes" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
2000 | 1 | 1 | 2 |
2001 | 2 | 0 | 2 |
2002 | 2 | 0 | 2 |
2003 | 0 | 1 | 1 |
2004 | 2 | 0 | 2 |
2005 | 0 | 2 | 2 |
2006 | 1 | 1 | 2 |
2007 | 0 | 2 | 2 |
2008 | 1 | 2 | 3 |
2009 | 1 | 0 | 1 |
2010 | 0 | 2 | 2 |
2012 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Immunoglobulin Idiotypes" by people in Profiles.
-
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects. Front Immunol. 2024; 15:1345499.
-
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. N Engl J Med. 2022 Jan 27; 386(4):394-396.
-
B-cell lymphomas present immunoglobulin neoantigens. Blood. 2019 02 21; 133(8):878-881.
-
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma. J Clin Oncol. 2014 Jun 10; 32(17):1797-803.
-
A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica immunoglobulin G binding to aquaporin-4. J Biol Chem. 2012 Oct 26; 287(44):36837-44.
-
Successful idiotypic vaccination following stem cell allotransplant in lymphoma. Leuk Lymphoma. 2013 Apr; 54(4):881-4.
-
B-cell fate decisions following influenza virus infection. Eur J Immunol. 2010 Feb; 40(2):366-77.
-
A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma. J Immunother. 2010 Feb-Mar; 33(2):178-84.
-
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma. Leuk Lymphoma. 2009 Jan; 50(1):37-46.
-
Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines. Mol Immunol. 2009 Jan; 46(3):448-56.